| Name | 8-bromo-1,3,4,5-tetrahydro-1-benzazepin-2-one |
|---|---|
| Synonyms |
8-bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one
8-Bromo-1,3,4,5-tetrahydrobenzo[b]azepine-2-one 8-bromo-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 8-bromo-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one |
| Density | 1.475g/cm3 |
|---|---|
| Boiling Point | 370.2ºC at 760 mmHg |
| Molecular Formula | C10H10BrNO |
| Molecular Weight | 240.09600 |
| Flash Point | 177.7ºC |
| Exact Mass | 238.99500 |
| PSA | 29.10000 |
| LogP | 2.86190 |
| Index of Refraction | 1.58 |
| HS Code | 2933990090 |
|---|
|
~64%
885953-12-8 |
| Literature: XENON PHARMACEUTICALS INC. Patent: WO2008/46046 A1, 2008 ; Location in patent: Page/Page column 75 ; WO 2008/046046 A1 |
|
~89%
885953-12-8 |
| Literature: Alantos Pharmaceuticals, Inc., Patent: US2006/173183 A1, 2006 ; Location in patent: Page/Page column 106-107 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |